Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
The company is committed to revolutionizing API development by advancing synthesis and analytical processes that enhance quality and impact lives
Revenue share from the North America increased to 79% in Q2 FY25 as compared to 67% in Q2 FY24
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
The company reported total income at Rs. 509.8 crore in Q1 FY25 as compared to Rs. 570.3 crore in Q1 FY24
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
The EIR was issued post the last inspection of the facility conducted from May 6-10, 2024 which concluded with zero FDA 483 observations
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
The acquisition will further strengthen Barentz’ position in India creating a leading life science distribution platform
Subscribe To Our Newsletter & Stay Updated
